|
|
[PQC-3] A Metabolic Pathway Activation Marker for Prostate Cancer Prognosis
|
5R01CA185251-04
|
$700,207
|
$700,207
|
BEEBE, DAVID
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
Yale SPORE in Skin Cancer
|
3P50CA121974-10S1
|
$25,000
|
$3,000
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
|
Yale SPORE in Skin Cancer
|
3P50CA121974-10S2
|
$709,079
|
$85,089
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
|
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
|
5P50CA196530-03
|
$2,300,000
|
$805,000
|
HERBST, ROY
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S1
|
$117,999
|
$16,520
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S2
|
$60,000
|
$8,400
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S3
|
$125,625
|
$17,588
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S4
|
$200,000
|
$28,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S5
|
$250,000
|
$35,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-38
|
$2,600,006
|
$364,001
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
WNT4 IN ENDOCRINE RESPONSE AND RESISTANCE IN INVASIVE LOBULAR CARCINOMA
|
4R00CA193734-03
|
$249,000
|
$124,500
|
SIKORA, MATTHEW
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Wnt/?-catenin Signaling in Pancreatic Oncogenesis
|
1R01CA220236-01
|
$366,000
|
$366,000
|
XIE, KEPING
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
Wnt pathway dynamics in breast cancer metastasis
|
1K22CA207463-01
|
$188,042
|
$188,042
|
ROARTY, KEVIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Wiskott-Aldrich syndrome protein (WASp) signaling in the oncogenesis of T cell lymphomas
|
1K08CA218460-01
|
$106,531
|
$53,266
|
MURGA-ZAMALLOA, CARLOS
|
UNIVERSITY OF MICHIGAN
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-09
|
$2,524,399
|
$454,392
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S1
|
$59,999
|
$10,800
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S2
|
$102,081
|
$18,375
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Weill Cornell Medicine (WCM) SPORE in Prostate Cancer
|
1P50CA211024-01A1
|
$2,184,999
|
$1,114,349
|
RUBIN, MARK
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
|
Water Soluble Polymers to Target Tumor-Associated Extracellular Matrix for Delivery of MMP Inhibitors
|
1F31CA213901-01A1
|
$44,044
|
$44,044
|
SUBRAHMANYAM, NITHYA
|
UNIVERSITY OF UTAH
|
|
|
Washington University SPORE in Pancreatic Cancer
|
5P50CA196510-02
|
$2,143,077
|
$171,446
|
HAWKINS, WILLIAM
|
WASHINGTON UNIVERSITY
|
|
|
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
|
5R01CA194404-03
|
$332,363
|
$332,363
|
BARBER, GLEN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
|
Vermont PROSPR Research Center (VPRC)
|
3U54CA163303-05S3
|
$608,939
|
$30,447
|
SPRAGUE, BRIAN
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
|
Vermont Breast Cancer Molecular Characterization Laboratory
|
3U01CA196383-03S1
|
$312,000
|
$156,000
|
STEIN, JANET
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
|
VEGF signaling in Mammary Tumorigenesis
|
2R01CA168464-06
|
$397,813
|
$397,813
|
MERCURIO, ARTHUR
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
|
|
VCU Massey Cancer Center Support Grant
|
2P30CA016059-36
|
$2,164,167
|
$216,417
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-36S1
|
$124,341
|
$12,434
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-36S2
|
$19,990
|
$1,999
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
Vascular communication in metastatic brain colonization
|
5R01CA184594-04
|
$321,625
|
$321,625
|
KLEMKE, RICHARD
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
Vascular Biology Section
|
ZIA BC 011390
|
$1,151,796
|
$345,539
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
|
Vangl Dependent PCP Signaling Mediates EMT Induced Cell Invasiveness
|
5F31CA210467-02
|
$38,596
|
$38,596
|
VANDERVORST, KACEY
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
|
Validation of Quantitative 11C-Erlotinib PET for Imaging EGFR-Mutant Lung Cancer
|
5R01CA195493-03
|
$255,891
|
$51,178
|
MORRIS, EVAN
|
YALE UNIVERSITY
|
|
|
Validation of circulating tumor DNA assays for detection of metastatic melanoma
|
5UH2CA206124-02
|
$248,101
|
$248,101
|
POLSKY, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
|
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
|
3U01CA200466-02S1
|
$129,694
|
$64,847
|
BRAND, RANDALL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Validation of biomarkers for early diagnosis and risk prediction of pancreatic neoplasms
|
5U01CA200466-02
|
$1,537,769
|
$768,885
|
BRAND, RANDALL
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
|
Validating and Characterizing a New Melanoma Therapeutic Target
|
1R01CA217625-01
|
$646,803
|
$323,402
|
COURTNEIDGE, SARA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S1
|
$125,000
|
$17,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S2
|
$31,772
|
$4,448
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-43
|
$4,288,496
|
$600,389
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
Using the Collaborative Cross for Model Studies of Intestinal Cancer
|
5R21CA202496-02
|
$169,650
|
$42,413
|
SIRACUSA, LINDA
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Using Single Cell Analysis to identify therapeutic vulnerabilities in leptomeningeal melanoma metastases
|
1R21CA216756-01
|
$187,050
|
$187,050
|
SMALLEY, KEIRAN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
Using Second Harmonic Generation to Predict Metastatic Outcome in Colon Adenocarcinoma
|
1R21CA208921-01A1
|
$200,807
|
$200,807
|
BROWN, EDWARD
|
UNIVERSITY OF ROCHESTER
|
|
|
Using DNA methylation markers to improve the predictive accuracy and utility of needle biopsiesfor determining prostate cancer aggressiveness
|
5R21CA201865-02
|
$179,438
|
$179,438
|
LIANG, GANGNING
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
Use of Mouse Models of Human Rhabdomyosarcoma to Study Progression to Metastasis
|
ZIA BC 010871
|
$27,615
|
$19,330
|
Merlino, Glenn
|
CCR (NCI)
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-42S1
|
$59,999
|
$11,400
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-42
|
$6,263,488
|
$1,190,063
|
Wayne, Alan
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
UPR/MDACC Partnership for Excellence in Cancer Research (2 of 2)
|
5U54CA096297-15
|
$1,391,697
|
$473,177
|
CRUZ-CORREA, MARCIA
|
UNIVERSITY OF PUERTO RICO MED SCIENCES
|
|
|
Unraveling the molecular control of a pro-metastatic regulatory network in melanoma
|
5R01CA184804-02
|
$387,731
|
$387,731
|
TAVAZOIE, SOHAIL
|
ROCKEFELLER UNIVERSITY
|
|
|
Unraveling resistance to PI3K-alpha inhibitors in breast cancer
|
5R01CA190642-03
|
$436,922
|
$218,461
|
BASELGA, JOSE
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
|
Unlocking Tumor Immunophenotype in Responders versus Non-Responders in Metastatic Uveal Melanoma Patients Receiving Immune Checkpoint Blockade
|
5R21CA208609-02
|
$174,000
|
$174,000
|
PATEL, SAPNA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
University of Virginia Cancer Center Support Grant
|
2P30CA044579-26
|
$2,574,504
|
$308,940
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
Total relevant funding to Metastasis for this search: $427,988,852
|
